FDA recalls transseptal sheath kit

Candace Stuart | | Cardiovascular Business | Interventional Cardiology

The FDA has issued a Class 1 recall of the TorFlex Transseptal Guiding Sheath Kit, a device used in cardiac catheterization procedures.

Baylis Medical Company sent a letter to customers on Sept. 23 that announced an urgent device recall of 1,035 kits manufactured between Dec. 22, 2011, and July 4, 2013. The device includes a sheath, a dilator and a J-tipped guidewire. The sheath could remove particulate of less than 5 mm from the dilator, according to the FDA, and the particulate could potentially migrate into a patient’s bloodstream.

Physicians and hospitals should quarantine the devices and report any adverse events related to the product.

The affected lot numbers are available here.

Candace Stuart, Contributor

Related Content

Surgery outperforms PCI in NSTEMI patients with multivessel CAD
Boston Scientific enters IVL arms race with acquisition worth up to $664M
FDA sees value in no-implant heart failure device
Radial secondary access during TAVR limits complications
Medtronic’s Harmony TPVR system gains CE mark approval
History made: Young child treated with new heart device for very first time

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.